Local Anaesthetics Flashcards

1
Q

what do nerve and muscle cell produce for electrical excitability

A
  • they generate propagated action potentials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the purpose of the action potentials?

A

in nerve cells: communication in nervous system

in muscle cells: initiation of mechanical activity in cardiac and striated muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When does the voltage-gated sodium channels open?

A

they open transiently when membrane is depolarised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why Na+ can only enter the cells intracellularly through a sodium channel?

A
  • they are ions vs phospholipid mem
  • always from extracellular (more Na outside) to intracellular
  • resting potential inside cell is negative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 types of voltage-gated sodium channel receptor states that prevents Na+ from entering the cell

A
  1. inactivated state: ion flow blocked by gating mechanism (BUT not the closing of the channel itself)
  2. deactivation state: ion flow blocked by closing of the channel + gate closed
  3. resting (closed) state: channel is closed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the four receptor states of a voltage-gated sodium channel?

A
  1. closed (gating mechanism not closed, channel closed)
  2. activated
  3. inactivated (gating mechanism closed)
  4. deactivated (both gating mechanism and channel closed)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the MOA of LA?

A

stop axonal conduction by blocking sodium channels in the axonal membrane when applied locally in appropriate concentration –> prevent sodium ion entry –> slow down or bring conduction to a halt

  • bind mostly to inactivated and activated states
    note: the passage of train of action potentials causes the open [activated] and inactivated states of VG sodium channels –> causing the depolarisation which causes the pain signal to be activated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how does the LA enter the cell and causes its therapeutic action?

A

LAs are weak bases; which converts into more into B form in physiological pH and enters the cell through the phospholipid membrane

inside the cell, the B protonates to B-H+ to be able to exert its therapeutic action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why is LA’s MOA based on use-dependency?

A

its depth of LA nerve block is more potent/better with increased frequency of action potentials (more cycles of open [activated] and inactivated states) as:

  1. it can gain access to the channel more readily when channel is open
  2. have higher affinity for the inactivated than for the resting (closed) channels
    e. g. when person is in more pain compared to the rest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

LA binds to which VG sodium channels?

A
  • they are non-selective modifiers of neuronal function –> block action potentials in ALL neurons that they have access to
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how to achieve selectivity for LAs?

A

deliver the LA to a limited area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the factors affecting LA’s action

A
  1. more lipid soluble drugs are more potent and act longer
    - more hydrophobic: tetracaine, etidocaine, bupivacaine
    - less hydrophobic: lidocaine, procaine, mepivacaine

Acts on all nerves BUT:

    • size: smaller > bigger
    • myelination: myelinated > non-myelinated
    • freq of firing: high (sensory) > low (motor)
    • position: circumferential (skin surface) > deep (large nerve trunk)
  1. pH dependency
    - LA are weak bases (pKa 8-9), mainly (but not completely) ionised at physiological pH
  • in alkaline pH –> increased LA activity (low proportion of ionized molecules)
  • acidic pH –> decreased LA activity (high proportion of ionized molecules)

(pH is IMPT in LA penetrate nerve sheath and axon membrane to reach the inner end of the sodium channel (LA binding site))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which axons will LA have greater potency?

A

small myelinated axons > small non-myelinated axons > large myelinated axons

therefore,
nociceptive & sympathetic transmission is blocked first (their axons are small +/- myelinated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

which fibre types have greater sensitivity to block by LAs? (most sensitive [++++] to +++)

A
  1. type C dorsal root (pain): diameter 0.4-1.2um; no myelination [++++]
  2. type C sympathetic (postganglionic): diameter 0.3-1.3; no myelination [++++]
  3. type B (preganglionic autonomic): diameter <3um; light myelination [++++]
  4. type A delta (pain & temp): Diameter 2-5um; heavy myelination [+++]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the names of the ester LA?

A

Cocaine, Procaine (Novocain), Tetracaine (Pontocaine), Benzocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the names of the amide LA?

A

Lidocaine (Lignocaine), Mepivacaine, Bupivacaine, Etidocaine, Prilocaine, Ropivacaine

17
Q

what is the difference between ester and amide type?

A

ester vs amide type:

chemistry: ester vs amide bond

representative agents: procaine vs lidocaine

incidence of allergic rxns: low vs very low

method of metabolism: plasma/tissue non-specific esterases vs hepatic enzymes (impt for pt w liver problems)

18
Q

what is the A and D of LA’s PK?

A

A: mainly local action (but do note LA still gets absorbed into blood –> and its determined by blood flow to the site of administration)

D: systemic –> 2-compartment model

a. Phase I (alpha phase): steep exponential decline in [LA]
- rapid distribution in blood and highly perfused organs (brain, liver, heart, kidney)

followed by Phase II (B phase): slower decline in LA; assume a nearly linear rate of decline
- distributed to less well-perfused tissue (muscle, gut)

19
Q

what is the onset and M of LA’s PK?

A

Onset: LA that penetrate the axon the fastest –> fastest onset
= small size, high lipid solubility, low ionisation (@tissue pH)

M: ester-type by esterases in blood
amide-type by enzymes in liver

20
Q

how does toxicity occur with LA

A
  1. unintended large dose (IV/intra-arterial scenario)

or 2. overdose of LA injected locally
–> lead to high & toxic blood level following absorption, systemic toxicity

  • for overdose at local site, onset of toxic sx & signs may appear late as compare to the direct IV scenario (the immediate one)
21
Q

what can we add to LA to prevent possible systemic toxicity?

A
  • epinephrine –> prevent LA systemic distribution from the site of action
22
Q

what are the specific toxicity that can be caused by each LA? (4 drugs)

A
  1. bupivacaine: more cardiotoxic than most other LAs (CVS –> cardiovascular collapse) (careful in heart patients)
  2. cocaine: blocks NA reuptake, increases NA causes vasoconstriction and HTN (more NA in the synapse)
    note: cocaine not given in usual clinical practice
  3. Prilocaine –> its metabolite = O-toluidine causes methaemoglobin (O2 exchange compromised)
    solution: IV methyleneblue/ ascorbic acid –> converts methaemoglobin to Hb
  4. Ester LAs hydrolysed to p-aminobenzoic acid (PABA) derivatives –> allergic rxns in small % of population
23
Q

What are the clinical applications for LAs?

A
  1. Topical (surface)
    - skin = minor burns/inflamed/wounds
  • eyes = remove foreign obj
  • dental = applied to gum due to entry of injection needle
  • Otorhinolaryngology (gastric ulcer scope)
  • Gynaecology (episiotomy cuts = lidocaine
  1. Injected
    - Epidural anaesthetics = nerve block (analgesia)
    –> Lidocaine, bupivacaine
    (may + opoid fentanyl to reduce LA dose)
  • Dental anaesthesia
    –> Lidocaine (short-acting)
    –> bupivacaine (long acting)
    (may +epinephrine –> vasoconstrictor –> control bleeding)
24
Q

What LAs should i choose?

A
  • based on DOA
  • surface anesthesia requires rapid penetration of skin (mucosa) and limited tendency to diffuse away
    (e. g. lidocaine, tetracaine, benzocaine)
  • cocaine = good penetration and vasoconstriction –> thus used in ENT procedures (but in SG, little in clinical use)